Researchers model familial amyloidosis in vitro using iPSC technology

Researchers from Boston University School of Medicine and Boston Medical Center have generated the first known disease-specific induced pluripotent stem cell lines from a patient with familial transthyretin amyloidosis .

http://www.eurekalert.org/pub_releases/2013-10/bumc-rmf103113.php